Peregrine lands $5.75 million investment

Biopharmaceutical firm Peregrine Pharmaceuticals has closed an offering for $5.75 million from six institutional investors, including a director at the Tustin, CA-based firm. With the new investment, Peregrine said it now has $11.6 million in cash to fund its clinical trials, contract manufacturing operations, and R&D. The offering was led by Zimmer Lucas Partners of New York City.

By AuntMinnie.com staff writers
November 19, 2001

Related Reading

Biopharmaceutical firm Peregrine hawks new agents, September 19, 2001


Copyright © 2001 AuntMinnie.com

Page 1 of 3503
Next Page